Insider Transactions in Q2 2025 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 03
2025
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,134
+8.45%
|
$22,268
$2.1 P/Share
|